Brian J. Lynch - Jan 3, 2023 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
SVP and General Counsel
Signature
/s/ Brian J. Lynch
Stock symbol
MDGL
Transactions as of
Jan 3, 2023
Transactions value $
-$2,484,707
Form type
4
Date filed
1/6/2023, 08:08 AM
Previous filing
Dec 28, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Options Exercise $1.19M +13K $91.79 13K Jan 3, 2023 Direct F1
transaction MDGL Common Stock Sale -$167K -600 -4.62% $277.91 12.4K Jan 3, 2023 Direct F1, F3
transaction MDGL Common Stock Sale -$112K -400 -3.23% $279.10 12K Jan 3, 2023 Direct F1, F4
transaction MDGL Common Stock Sale -$505K -1.8K -15% $280.66 10.2K Jan 3, 2023 Direct F1, F5
transaction MDGL Common Stock Sale -$749K -2.66K -26.04% $281.97 7.54K Jan 3, 2023 Direct F1, F6
transaction MDGL Common Stock Sale -$744K -2.63K -34.84% $282.97 4.92K Jan 3, 2023 Direct F1, F7
transaction MDGL Common Stock Sale -$440K -1.55K -31.51% $283.85 3.37K Jan 3, 2023 Direct F1, F8
transaction MDGL Common Stock Sale -$236K -829 -24.62% $285.15 2.54K Jan 3, 2023 Direct F1, F9
transaction MDGL Common Stock Sale -$582K -2.04K -80.3% $285.74 500 Jan 3, 2023 Direct F1, F10
transaction MDGL Common Stock Sale -$115K -400 -80% $286.62 100 Jan 3, 2023 Direct F1, F11
transaction MDGL Common Stock Sale -$28.8K -100 -100% $287.86 0 Jan 3, 2023 Direct F1, F12
holding MDGL Common Stock 530 Jan 3, 2023 In IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Options Exercise $0 -13K -52% $0.00 12K Jan 3, 2023 Common Stock 13K $91.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 All shares issued pursuant to the exercise of the options reported herein represent 13,000 shares underlying an overall option award of 32,000 shares. All exercised options had vested. As to the overall option for 32,000 shares, 25% of the shares underlying the option vested on March 5, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.90 to $277.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.06 to $279.38, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.22 to $281.16, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.32 to $282.30, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.41 to $283.33, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.42 to $284.21, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.50 to $285.49, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.50 to $286.29, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.61 to $286.63, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.86 to $287.86, inclusive.